Israel Englander’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28M Sell
653,503
-937,527
-59% -$3.02M ﹤0.01% 3712
2026
Q1
$4.58M Buy
1,591,030
+967,788
+155% +$3.81M ﹤0.01% 3047
2025
Q4
$2.54M Sell
623,242
-996,758
-62% -$4.46M ﹤0.01% 3733
2025
Q3
$5.75M Buy
1,620,000
+822,423
+103% +$2.97M ﹤0.01% 2991
2025
Q2
$2.18M Buy
797,577
+560,448
+236% +$1.16M ﹤0.01% 3808
2025
Q1
$398K Sell
237,129
-491,772
-67% -$1.37M ﹤0.01% 4939
2024
Q4
$1.19M Buy
728,901
+675,481
+1,264% +$2.01M ﹤0.01% 4056
2024
Q3
$222K Sell
53,420
-104,628
-66% -$550K ﹤0.01% 5380
2024
Q2
$863K Buy
158,048
+145,710
+1,181% +$1.16M ﹤0.01% 4199
2024
Q1
$123K Sell
12,338
-2,183,463
-99% -$16.4M ﹤0.01% 5529
2023
Q4
$8.96M Buy
2,195,801
+1,682,828
+328% +$6.2M ﹤0.01% 2293
2023
Q3
$1.99M Sell
512,973
-79,372
-13% -$427K ﹤0.01% 3552
2023
Q2
$3.53M Buy
592,345
+258,458
+77% +$1.49M ﹤0.01% 2975
2023
Q1
$1.09M Sell
333,887
-96,544
-22% -$386K ﹤0.01% 4008
2022
Q4
$1.7M Sell
430,431
-381,371
-47% -$1.86M ﹤0.01% 3699
2022
Q3
$4.87M Buy
811,802
+796,266
+5,125% +$5.75M ﹤0.01% 2908
2022
Q2
$100K Buy
+15,536
New +$99K ﹤0.01% 5929
2022
Q1
Sell
-20,098
Closed -$311K 7410
2021
Q4
$311K Buy
+20,098
New +$387K ﹤0.01% 5500

Other funds holding SANA

Israel Englander's SANA Position: Q2 2026 in Review

Israel Englander reduced its Sana Biotechnology (SANA) stake by 59% in Q2 2026, selling an estimated $3.02M and leaving 653,503 shares worth $2.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3712.

Israel Englander first reported a position in SANA in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.96M in Q4 2023. 208 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Israel Englander held 653,503 shares of Sana Biotechnology worth $2.28M as of Q2 2026.
  • Israel Englander sold 937,527 Sana Biotechnology shares in Q2 2026, an estimated $3.02M.
  • Sana Biotechnology made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3712 holding.
  • Israel Englander first reported a position in Sana Biotechnology in Q4 2021 and has held it in 18 quarters since.
  • Israel Englander's Sana Biotechnology position peaked at $8.96M in Q4 2023.
  • 208 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.